CoLucid Pharmaceuticals, Inc. CLCD was a big mover last session, as its shares rose over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally continues the uptrend for the company since May 19, as the stock is now up over 22%.
Over the last 30 days, the company witnessed four negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s move higher lasts.
CoLucid Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked biomedical stock is ANI Pharmaceuticals, Inc. ANIP with a Zacks Rank #1 (Strong Buy).
Is CLCD going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment